NON PHARMACOLOGICAL THERAPIES FOR ALZHEIMER'S

.

.
 
.
 

.

.INDEX PROFESSORS
.
 
 

 

 

 

Javier Olazarán

 

 

PERSONAL DATA

 

Name: Javier Olazarán.
Place and date of birth: Pamplona, Spain, June 3rd, 1965.
Address: Fermín Caballero 30-13B, E-28034 Madrid, Spain.
Phone number: 34-91-730-6051.
Fax number: 00-91-433-6033.
E-mail: javier@mariawolff.es

ACADEMIC ACHIEVEMENTS

1989.  Degree in Medicine and Surgery.  University of Navarra, Spain.
1993.  Degree in Neurology.  University Hospital Gregorio Marañón,  Madrid, Spain.
1994. Clinical Research Fellowship in Behavioral Neurology. Columbia Presbiterian Medical Center, New York (Director: Dr.    Richard Mayeux).
1997.  Doctoral thesis ‘Validity of cognitive complaints in the elderly:  data from a population-based study’.  Thesis directors: Dr. Félix Bermejo and Dr. Jordi Peña-Casanova.  Complutense University  of Madrid, Spain.

CURRENT POSITIONS

1995- Neurologist at Neurology Office of Hermanos Sangro Specialties Clinic.  National System of Health, Madrid, Spain.
1995- Member of Maria Wolff Foundation (private foundation for the research and development of non-pharmacological therapies in Alzheimer’s disease and related disorders).  Madrid, Spain.
1999- Neurologist at the Behavioral Neurology Unit of Gregorio Marañón University Hospital.  National System of Health, Madrid, Spain.

MOST RELEVANT PUBLICATIONS

- Olazarán J, Jacobs DM, Stern Y. Comparative study of visual and verbal short-term memory in English and Spanish speakers: testing a linguistic hypothesis. Journal of the International Neuropsychological Society 1996; 2: 105-10.

- Muñiz R, Morillas N, Olazarán J, González MJ, Neira M, Perea M. Group management of dementia patients in a day-care center. International Psychogeriatrics 2000; 12 (Suppl 1): 367-372.

- Olazarán J, Trincado R, Bermejo F, Benito-León J, Díaz J, Vega S. Selective memory impairment on an adapted Mini-Mental State Examination increases risk of future dementia.  International Journal of Geriatric Psychiatry 2004; 19: 1173-1180. 

- Olazarán J, Muñiz R, Reisberg R, Peña-Casanova J, del Ser T, Cruz-Jentoft AJ, Serrano P, Navarro E, García de la Rocha ML, Frank A, Galiano M, Fernández-Bullido Y, Serra JA, González-Salvador MT, Sevilla C. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer’s disease. Neurology 2004; 63: 2348-2353.

- Olazarán J, Muñiz R. Cognitive intervention in the initial stages of Alzheimer’s disease. Research and Practice in Alzheimer’s Disease 2006; 11: 376-380.      

- Olazarán J, Cruz I, Benito-León J, Morales JM, Duque P, Rivera-Navarro J. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study. Eur Neurol 2009; 61: 87-93.

- Olazarán J, López-Longo J, Cruz I, Bittini A, Carreño L. Cognitive dysfunction in systemic Lupus erythematosus: prevalence and correlates. Eur Neurol 2009; 62: 49-55.

- Bermejo-Pareja F, Benito-Leon J, Vega S, Olazaran J, de Toledo M, Diaz-Guzman J, Sanchez-Sanchez F, Morales-Gonza Lez JM, Trincado R, Portera-Sanchez A, Roman GC. Consistency of clinical diagnosis of Dementia in NEDICES: a population-based longitudinal study in Spain. J Geriatr Psychiatry Neurol 2009, 22: 246-255.

- Boada M, Ortiz P, Anaya F, Hernández I, Muñoz J, Núñez L, Olazarán J, Roca I, Cuberas G, Tárraga L, Buendía M, Pla RP, Ferrer I, Páez A. Amyloid-targeted therapeutics in Alzheimer’s disease: use of human albumin in plasma exchange as a novel approach for Aβ mobilization. Drug News & Perspectives 2009; 22: 325-339.

- León-Salas B, Olazarán J, Muñiz R, González-Salvador MA, Martínez-Martín P. Caregivers' estimation of patients' quality of life (QoL) in Alzheimer's disease (AD): An approach using the ADRQL. Arch Gerontol Geriatr 2010 Jun 21. [Epub ahead of print]

- Olazarán J, Prieto J, Cruz I, Esteban A. Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study. J Neurol 2010 Jul 31. [Epub ahead of print]